Seeking Alpha

In another blow to Roche’s (RHHBY.PK) hostile grab for gene-sequencing company Illumina...

In another blow to Roche’s (RHHBY.PK) hostile grab for gene-sequencing company Illumina (ILMN -0.7%), proxy adviser Glass Lewis recommends shareholders support ILMN’s board in its proxy fight, joining ISS and Egan-Jones. ILMN says it is pleased to have all three well-known shareholder advisers on its side.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs